Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

28.7K
Overview
28.7K
Viral Meningitis01:18

Viral Meningitis

199
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
199
Vaccinations01:51

Vaccinations

44.1K
Overview
44.1K
Vaccines01:21

Vaccines

98
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
98
Arboviral Encephalitis01:25

Arboviral Encephalitis

59
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
59
Vaccine Production01:23

Vaccine Production

144
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
144

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics of Sleep Paralysis and Its Association With PTSD, Stress, and Other Lifestyle Variables Among the Population of Pakistan, a Cross-Sectional Study.

Public health challenges·2026
Same author

Efficacy and safety of risankizumab in moderate to severe psoriasis: an updated systematic review and meta-analysis.

Annals of medicine and surgery (2012)·2026
Same author

Extrahepatic Biliary Atresia With Situs Inversus and Ventricular Septal Defect: A Case Report.

Clinical medicine insights. Case reports·2026
Same author

Combination pitavastatin-ezetimibe therapy for hypercholesterolemia and mixed dyslipidemia: a systematic review and meta-analysis.

Future cardiology·2026
Same author

Operationalizing preparedness: bridging the "Know-Do" gap in Rwanda's infectious disease policy.

International journal of emergency medicine·2026
Same author

Unusual metastasis of breast cancer to the paranasal sinuses: a case report.

Journal of medical case reports·2026

Related Experiment Video

Updated: May 5, 2026

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
10:01

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

Published on: October 17, 2018

11.2K

Vimkunya vaccine: a breakthrough in combating chikungunya.

Muhammad Mudasir1, Warisha Kanwal2, Kaneez Narjis3

  • 1Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan.

Annals of Medicine and Surgery (2012)
|May 4, 2026
PubMed
Summary

A new chikungunya virus (CHIKV) vaccine, Vimkunya, shows high efficacy and a safe profile. This virus-like particle vaccine offers a promising strategy to combat chikungunya outbreaks globally.

Area of Science:

  • Virology
  • Immunology
  • Public Health

Background:

  • Chikungunya virus (CHIKV) poses a significant global health threat, transmitted by Aedes mosquitoes, causing debilitating symptoms.
Keywords:
PXVX0317Vimkunya vaccinechikungunya virus (CHIKV)public healthvirus-like particle (VLP)

More Related Videos

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
06:18

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

14.4K
A Multiplex Serological Assay for the Detection of Antibody Responses to Arboviruses
05:22

A Multiplex Serological Assay for the Detection of Antibody Responses to Arboviruses

Published on: November 4, 2025

1.1K

Related Experiment Videos

Last Updated: May 5, 2026

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
10:01

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

Published on: October 17, 2018

11.2K
Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
06:18

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

14.4K
A Multiplex Serological Assay for the Detection of Antibody Responses to Arboviruses
05:22

A Multiplex Serological Assay for the Detection of Antibody Responses to Arboviruses

Published on: November 4, 2025

1.1K
  • In 2024, CHIKV outbreaks resulted in over 620,000 reported cases and 213 fatalities worldwide.
  • Existing vaccine candidates faced challenges, necessitating safer and more effective alternatives.